Giuseppina Barutello

878 total citations
29 papers, 675 citations indexed

About

Giuseppina Barutello is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Giuseppina Barutello has authored 29 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Giuseppina Barutello's work include Immunotherapy and Immune Responses (13 papers), Virus-based gene therapy research (7 papers) and Cancer Cells and Metastasis (6 papers). Giuseppina Barutello is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Virus-based gene therapy research (7 papers) and Cancer Cells and Metastasis (6 papers). Giuseppina Barutello collaborates with scholars based in Italy, Sweden and United States. Giuseppina Barutello's co-authors include Federica Cavallo, Federica Riccardo, Elena Quaglino, Laura Conti, Valeria Rolih, Maddalena Arigoni, Elisabetta Bolli, Stefania Lanzardo, Roberto Ruiu and Paolo Buracco and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Giuseppina Barutello

27 papers receiving 667 citations

Peers

Giuseppina Barutello

IMMUN

ONCOL

PRM

Elisa Melucci Italy

Kavitha Balaji United States

Simone Gaedicke Germany

Josefine Gerhardt Switzerland

Chi-Ping Day United States

Robert E. Reeves United States

Yuan‐Tong Liu China

H. Carlo Maurer United States

Sheri Nixdorf Australia

Sheila Spada United States

Elisa Melucci Italy

Giuseppina Barutello

421 ×1.5

144 ×0.6

IMMUN

465 ×2.7

ONCOL

108 ×0.8

PRM

244 ×2.0

Citations per year, relative to Giuseppina Barutello Giuseppina Barutello (= 1×) peers Elisa Melucci

Countries citing papers authored by Giuseppina Barutello

Since Specialization

Citations

This map shows the geographic impact of Giuseppina Barutello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Barutello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Barutello more than expected).

Fields of papers citing papers by Giuseppina Barutello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Barutello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Barutello. The network helps show where Giuseppina Barutello may publish in the future.

Co-authorship network of co-authors of Giuseppina Barutello

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Barutello. A scholar is included among the top collaborators of Giuseppina Barutello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Barutello. Giuseppina Barutello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curcio, Claudia, Silvia Brugiapaglia, Cecilia Roux, et al.. (2025). The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma. Clinical and Translational Medicine. 15(8). e70442–e70442.

Riccardo, Federica, Laura Conti, Lidia Tarone, et al.. (2024). Cancer vaccines: Target antigens, vaccine platforms and preclinical models. Molecular Aspects of Medicine. 101. 101324–101324. 14 indexed citations

Macagno, Marco, Elisabetta Bolli, Federica Riccardo, et al.. (2022). Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines. 10(2). 230–230. 1 indexed citations

Barutello, Giuseppina, et al.. (2022). Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines. 10(11). 2843–2843. 4 indexed citations

Riccardo, Federica, Lidia Tarone, Selina Iussich, et al.. (2022). Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial. Journal for ImmunoTherapy of Cancer. 10(5). e004007–e004007. 14 indexed citations

Ruiu, Roberto, Giuseppina Barutello, Maddalena Arigoni, et al.. (2021). Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. Cancers. 13(4). 894–894. 8 indexed citations

Conti, Laura, et al.. (2021). Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells. 10(1). 108–108. 19 indexed citations

Zhang, Yuanyuan, Giuseppina Barutello, Yujuan Zheng, et al.. (2021). The Amot/integrin protein complex transmits mechanical forces required for vascular expansion. Cell Reports. 36(8). 109616–109616. 15 indexed citations

Riccardo, Federica, Giuseppina Barutello, Lidia Tarone, et al.. (2020). Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas. Vaccines. 8(2). 166–166. 5 indexed citations

10.

Rolih, Valeria, Jerri C. Caldeira, Elisabetta Bolli, et al.. (2020). Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers. 12(6). 1492–1492. 28 indexed citations

11.

Ruiu, Roberto, Lidia Tarone, Valeria Rolih, et al.. (2019). Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source. Progress in molecular biology and translational science. 164. 119–188. 39 indexed citations

12.

Tarone, Lidia, Giuseppina Barutello, Selina Iussich, et al.. (2019). Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy. Cancer Immunology Immunotherapy. 68(11). 1839–1853. 42 indexed citations

13.

Ruiu, Roberto, Valeria Rolih, Elisabetta Bolli, et al.. (2018). Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter. Cancer Immunology Immunotherapy. 68(1). 131–141. 43 indexed citations

14.

Rolih, Valeria, Giuseppina Barutello, Selina Iussich, et al.. (2017). CSPG4: a prototype oncoantigen for translational immunotherapy studies. Journal of Translational Medicine. 15(1). 151–151. 57 indexed citations

15.

Zheng, Yujuan, Yuanyuan Zhang, Giuseppina Barutello, et al.. (2016). Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis. Scientific Reports. 6(1). 30622–30622. 24 indexed citations

16.

Pastò, Anna, Matteo Curtarello, Maddalena Arigoni, et al.. (2016). A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model. Oncotarget. 7(22). 33081–33095. 15 indexed citations

17.

Olgasi, Cristina, Patrizia Dentelli, Arturo Rosso, et al.. (2013). DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesis. European Journal of Cancer. 50(1). 234–246. 6 indexed citations

18.

Curcio, Claudia, Marco Macagno, Elena Quaglino, et al.. (2013). Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice. OncoImmunology. 2(9). e26137–e26137. 41 indexed citations

19.

Arigoni, Maddalena, Giuseppina Barutello, Federica Riccardo, et al.. (2013). miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas through Suppression of MID1 and MTCH2. American Journal Of Pathology. 182(6). 2058–2070. 53 indexed citations

20.

Arigoni, Maddalena, Giuseppina Barutello, Stefania Lanzardo, et al.. (2012). A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis. 15(2). 305–316. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact